Abattis Bioceuticals Corp. (ATTBF)

[ebota12]

The only possible way we see $2.50+ is with a CSL license and successful application of the liposome delivery method from Empirical labs. Who knows if CSL is even a possibility anymore, it seems we're on the naughty list.

The investor presentation said "Finalize Acquisition 1" timeframe was T-plus one month. The presentation was from May. That was two months ago.

If / when we do go through with an AQ, it's going to mean serious dilution.